)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
Seres Therapeutics
Seres Therapeutics (MCRB) investor relations material
Seres Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Apr, 2026
Executive summary
Annual Meeting scheduled for June 9, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 8, 2026.
Voting matters and shareholder proposals
Election of three directors: Stephen A. Berenson, Claire M. Fraser, Ph.D., and Richard N. Kender.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay).
Approval of amendment and restatement of the 2025 Incentive Award Plan to increase shares available.
Approval to adjourn the meeting if more time is needed to solicit votes for Proposal 4.
Board of directors and corporate governance
Board recommends voting in favor of all proposals and director nominees.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Seres Therapeutics
- Shareholders will vote on director elections, auditor ratification, executive pay, and an expanded equity plan.MCRB
Proxy filing27 Apr 2026 - Returned to profitability in 2025, focusing on SER-155 and SER-603, with cash runway into Q3 2026.MCRBQ4 202512 Mar 2026
- Leadership changes and SER-155 data in Q2 2026 highlight strategic and clinical progress.MCRBStatus update3 Mar 2026
- VOWST sale to Nestlé secures $155M upfront, funds pipeline, and extends cash runway into late 2025.MCRBInvestor Update2 Feb 2026
- VOWST sale to Nestlé boosts cash, retires debt, and shifts focus to biotherapeutic pipeline.MCRBQ2 20241 Feb 2026
- Significant reduction in bloodstream infections and antibiotic use with strong safety profile.MCRBStudy Result20 Jan 2026
- SER-155 reduced infections in allo-HSCT patients, driving pipeline focus and FDA engagement.MCRB2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- SER-155 cut BSIs by 77% in allo-HSCT patients; VOWST sale funded debt retirement and growth.MCRBQ3 202414 Jan 2026
- SER-155 achieved a 77% reduction in bloodstream infections, driving pivotal trial preparations.MCRBPiper Sandler 36th Annual Healthcare Conference12 Jan 2026
Next Seres Therapeutics earnings date
Q1 20266 May, 2026
Seres Therapeutics
Next Seres Therapeutics earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
Frequently asked questions
Explore our global coverage